Thus, upon Ang II stimulation, some CD34+ cells, potentially CD34+ fibroblast progenitors, can be activated and migrate to vulnerable sites where they proliferate and transdifferentiate into myofibroblasts, thereby protecting AAA from rupture. The gene discussed is CD34; the disease is triple-A syndrome.